Class IITerminatedD-0329-2015
Drug recall · January 7, 2015
GINSENG KIANPI PIL recall
Why: Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared dexamethasone and cyproheptadine which are FDA approved drugs making this product an unapproved drug.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
GINSENG KIANPI PIL, 60 capsules, PRODUCT OF KWEILIN DRUG MANUFACTORY
- Lots / codes
All lots
- Quantity
- 38 bottles
- Company
- One and Zen, Albuquerque, NM
- Distribution
- Nationwide
- Initiated
- November 20, 2014 · Voluntary: Firm initiated
- Classified
- December 30, 2014
- Reported
- January 7, 2015
- Ended
- March 23, 2015
- How notified
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.